1. Effect of Raltitrexed on ECA109 Cellular Radiosensitivity and its Mechanism in Esophageal Cancer.
- Author
-
Xu LB, Wu CY, Wang Y, and Zhou JY
- Subjects
- Humans, Dose-Response Relationship, Drug, Thiophenes pharmacology, Thioxanthenes pharmacology, Thioxanthenes chemistry, Radiation Tolerance drug effects, Cell Line, Tumor, Drug Screening Assays, Antitumor, Tumor Cells, Cultured, Cell Movement drug effects, Esophageal Neoplasms pathology, Esophageal Neoplasms drug therapy, Esophageal Neoplasms metabolism, Quinazolines pharmacology, Cell Proliferation drug effects, Apoptosis drug effects
- Abstract
Background: To investigate the effect of raltitrexed + X-ray irradiation on esophageal cancer ECA109 cells and analyze the potential action mechanism., Methods: The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to analyze the inhibitory effect of raltitrexed on cell proliferation. The effect of raltitrexed on radiosensitivity was studied through a clone-forming experiment. The scratch assay and invasion test were performed to understand the cell migration and invasion abilities. The apoptosis rate change was measured using a flow cytometer, and Western Blotting was used to determine the expression of B cell lymphoma-2 (Bcl-2) and Bcl2-associated X protein (Bax) in each group., Results: Raltitrexed significantly inhibited ECA109 proliferation in a time-dose-dependent manner; there were significant differences among different concentrations and times of action. The results of the clone-forming experiment showed a sensitization enhancement ratio of 1.65, and this demonstrated a radiosensitization effect. After the combination of raltitrexed with X-ray, the cell migration distance was shortened, and the number of cells penetrating the membrane was reduced., Conclusion: Raltitrexed can inhibit the growth of esophageal cancer ECA109 cells and has a radiosensitization effect., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2024
- Full Text
- View/download PDF